期刊文献+

胸水内容物包埋制片在恶性胸腔积液诊断中的临床价值 被引量:2

The clinical value of pleural fluid embedding in the diagnosis of malignant pleural effusion
下载PDF
导出
摘要 目的探讨胸水内容物包埋制片在恶性胸腔积液诊断中的临床价值。方法回顾我科2018-2019年间确诊为恶性胸腔积液、同时进行了胸水常规细胞学检查与胸水内容物包埋制片病例88例,比较胸水常规细胞学检查与胸水内容物包埋制片的确诊率。结果88例恶性胸腔积液患者行胸水常规细胞学检查确诊40例,确诊率45.45%;而进行胸水内容物包埋制片确诊68例,确诊率77.27%,差异具有统计学意义(P<0.05)。结论胸水内容物包埋制片对临床技术要求低,在病理诊断中能够获得更好的制片效果以及确诊率,有较高的临床应用价值。 Objective To explore the clinical value of pleural effusion embedding in the diagnosis of malignant pleural effusion.Methods A review of 88 cases of patients diagnosed as malignant pleural effusion in our department from 2018 to 2019 who underwent routine cytological examination of pleural effusion and prepared with pleural content embedding.To compare the diagnostic rate of routine cytological examination of pleural fluid with the method of embedding pleural fluid.Results Traditional methods of 88 patients with malignant pleural effusion with 40 patients with pleural effusion conventional cytology diagnosis,diagnosis rate was 45.45%,and chest water content embedding production method confirmed 68 cases of patients,diagnosis rate 77.27%,two groups of comparison,the chest water content embedding diagnosis rate of production method was obviously higher than that of hydrothorax conventional cytology(P<0.05),the difference is statistically significant.Conclusion The method of preparing pleural fluid with embedded contents has a low requirement on clinical technique,and it can obtain better preparation effect and diagnosis rate in pathological diagnosis,so it has a high clinical application value.
作者 郑洋 范存愈 卢丽君 Zheng Yang;Fan Cunyu;Lu Lijun(The Traditional Chinese Medicine Hospital of Wuhan City,Wuhan,Hubei 430000;The Hubei Provincial Hospital of Integrated Traditional Chinese and Western Medicine,Wuhan,Hubei 430000)
出处 《基层医学论坛》 2021年第1期35-37,共3页 The Medical Forum
关键词 恶性胸腔积液 胸水内容物 包埋制片 病因诊断 Malignant pleural effusion Pleural fluid contents Embedding method Etiological diagnosis
  • 相关文献

参考文献5

二级参考文献64

  • 1郭峰,卢兆桐,邹志强.原发性肺腺癌肿瘤标记物Napsin A的研究现状[J].国外医学(肿瘤学分册),2005,32(5):388-391. 被引量:4
  • 2童朝辉,王臻,王辰.内科胸腔镜技术及其临床应用[J].中华结核和呼吸杂志,2007,30(3):220-222. 被引量:86
  • 3Tatnell P J, Powell D J, Hill J, et al. Napsins: new human aspartie proteinases. Distinction between two closely related genes[J]. FEBS Lett, 1998,441(1):43-8.
  • 4Cronshaw R F, SchauerVukasinovic V, Powell D J, et al. Inhibition of human napsin A[J]. Protein Pept Lett, 2003,10(1):35-42.
  • 5Johnson H, Cohen C, Fatima N, et al. Thyroid transcription factor 1 and napsin a double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma[J]. Acta Cytol, 2012,56(6):5.
  • 6Agackiran Y, Ozcan A, Akyurek N, et al. Desmoglein3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other s.
  • 7Turner B M, Cagle P T, Sainz I M, et al. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosi.
  • 8Warth A, Muley T, Herpel E, et al. Largescale comparative analyses of immunomarkers for diagnostic subtyping of nonsmallcell lung cancer biopsies[J]. Histopathology, 2012,61(6):1017-25.
  • 9Liu L, Cohen C, Siddiqui M T, et al. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid[J]. Acta Cytol, 2012,56(4):425-30.
  • 10Mukhopadhyay S, Katzenstein A L. Comparison of monoclonal napsin A, polyclonal napsin A, and TTF1 for determining lung origin in metastatic adenocarcinomas[J]. Am J Clin Pathol, 2012,138(5):703-1.

共引文献257

同被引文献22

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部